Purchase Order 75N91025P00439

Award Date 7/15/25
Potential Completion Date 7/14/26
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute to Molecular Devices LLC, a division of Danaher Corporation, for a SERVICE AGREEMENT FOR SPECTRAMAX M3 MULTI-MODE MICROPLATE READER. The potential value of the contract is $14,122.00 and the completion date is June 24, 2025. Molecular Devices LLC is a major provider of high-performance bioanalytical measurement solutions for life sciences...
This is a firm-fixed-price purchase order awarded by the Smithsonian Institution, a civilian federal agency, to Molecular Devices LLC, a division of Danaher Corporation, for the purchase of a SpectraMax iD3 microplate reader. The total ceiling value of the contract is $36,746.26 and the ultimate completion date is February 29, 2024. No set-aside was used for this award. Molecular Devices LLC is a leading provider of high-performance bioanalytical measurement solutions for life science...
This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Molecular Devices LLC, a division of Danaher Corporation, for a service agreement with a potential value of $10,217.00. The contract does not have a set-aside designation and is scheduled for completion on June 8, 2025. Molecular Devices LLC is a leading provider of high-performance bioanalytical measurement solutions, such as...
This is a firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a division of Danaher Corporation. The contract is for a SPECTRAMAX ID3 SERVICE PLAN 1PM, ONSITE PERFORMANCE ASSURANCE with a ceiling value of $10,217.00 and a period of performance ending on October 31, 2025. The contract does not have a set-aside designation. Molecular Devices LLC is a leading provider of...
This firm-fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Molecular Devices LLC, a division of Danaher Corporation, to procure a SpectraMax iD3 multi-mode microplate reader. The $24,994.92 contract will replace an existing, non-functioning instrument due to software/operating system incompatibilities. Molecular Devices is a leading provider of bioanalytical measurement solutions and has received numerous prime federal contracts from agencies like the NIH,...
This is a firm-fixed-price purchase order awarded by the National Cancer Institute, a civilian agency within the U.S. government, to Molecular Devices LLC, a for-profit limited liability company. The contract is for the procurement of a SpectraMax L luminescence microplate reader with the current version of SoftMax Pro software, with a single photomultiplier tube and manual aperture. The contract has a ceiling value of $16,710.65 and a period of performance ending on August 31, 2025. There is no...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract is for the provision of a microplate reader and accessories with a ceiling value of $23,350.77. The contract has an ultimate completion date of November 14, 2014. Molecular Devices LLC is a for-profit limited liability company that specializes in advanced bioanalytical measurement solutions and has a strong presence in...
This is a $18,361.60 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency, to Molecular Devices LLC, a for-profit limited liability company, for a preventive maintenance agreement for a laboratory M5E plate reader. The contract has a period of performance through May 22, 2026. Molecular Devices is a subsidiary of Danaher Corporation and specializes in providing advanced bioanalytical measurement solutions and laboratory equipment to federal agencies...
This is a firm-fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract, valued at $7,332.00, is for a service plan for a SpectraMax M5 microplate reader system. This award does not have a set-aside designation. Molecular Devices LLC is a leading provider of bioanalytical measurement...
This federal contract award to Molecular Devices LLC, a division of Danaher Corporation, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for the purchase of a SpectraMax ID3 microplate reader. The $24,768.00 firm-fixed-price purchase order does not have a set-aside designation. Molecular Devices is a leading provider of high-performance bioanalytical measurement solutions for life science research,...

This is a firm-fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the National Institutes of Health, to Molecular Devices LLC, a for-profit limited liability company and subsidiary of Danaher Corporation. The contract is for a SERVICE AGREEMENT FOR SPECTRAMAX ID3 PLATE READER, with a ceiling value of $10,932.00 and a period of performance ending on July 14, 2026. The contract has no set-aside designation. Molecular Devices LLC is a manufacturer of advanced bioanalytical measurement solutions, including microplate readers, high-content imaging systems, and cellular screening platforms, which are commonly used in medical research, drug discovery, and public health initiatives supported by various federal agencies.

Generated 7/15/25, 3:37 PM